USG's other announcement today, its earnings report, also explodes the myths advanced by advocates of S.852, that the bill must be passed to save jobs lost through the enormous financial pain being endured by big corporate asbestos defendants. In its press release, the company reports 'Record Fourth Quarter 2005 Net Sales of $1.3 billion.' That the Senate would now shower companies like USG with even more benefits from S.852 is mind-boggling.
Tom O'Brien